The 'Effects of Transfusion Thresholds on Neurocognitive Outcome of Extremely Low Birth-Weight Infants (ETTNO)'

    Neonatology
    |February 3, 2012
    PubMed

    Insights

    Extremely low birth weight infants often need red blood cell transfusions (RBCTs). The ETTNO study will determine if restrictive or liberal transfusion guidelines best support neurocognitive outcomes in these vulnerable infants.

    Area of Science:

    • Neonatal Medicine
    • Pediatric Hematology
    • Neurodevelopmental Pediatrics

    Background:

    • Anemia of prematurity is common in extremely low birth weight (ELBW) infants.
    • Red blood cell transfusions (RBCTs) are frequently administered, but indications lack definitive evidence.
    • Current practices for RBCT in ELBW infants are controversial due to unknown long-term effects.

    Purpose of the Study:

    • To address the clinical equipoise surrounding red blood cell transfusion thresholds in ELBW infants.
    • To outline the protocol for the Effects of Transfusion Thresholds on Neurocognitive Outcome (ETTNO) study.
    • To investigate the impact of different RBCT guidelines on neurodevelopmental outcomes.

    Main Methods:

    • A comprehensive literature review was conducted.
    • A large, pragmatic randomized controlled trial (ETTNO study) was designed.
    • The trial will enroll 920 ELBW infants (400-999 g) comparing restrictive vs. liberal RBCT guidelines with long-term follow-up.

    Main Results:

    • The ETTNO study is designed to provide definitive data on transfusion efficacy and safety.
    • Results will elucidate the impact of RBCT thresholds on neurocognitive development.
    • The study aims to resolve the controversy regarding RBCT indications in preterm infants.

    Conclusions:

    • The ETTNO study will offer crucial evidence to guide clinical practice for RBCT in ELBW infants.
    • Findings will inform optimal transfusion strategies to improve long-term neurodevelopmental outcomes.
    • The study is expected to establish clear guidelines for RBCT in this high-risk population.